530
Views
23
CrossRef citations to date
0
Altmetric
Review Article

Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy

, , , , &
Pages 386-405 | Received 09 Sep 2016, Accepted 03 Jan 2017, Published online: 25 Jan 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Deep Shikha Sharma, Sheetu Wadhwa, Monica Gulati, Arya Kadukkattil Ramanunny, Ankit Awasthi, Sachin Kumar Singh, Rubiya Khursheed, Leander Corrie, Nitin Chitranshi, Vivek Kumar Gupta & Sukriti Vishwas. (2021) Recent advances in intraocular and novel drug delivery systems for the treatment of diabetic retinopathy. Expert Opinion on Drug Delivery 18:5, pages 553-576.
Read now

Articles from other publishers (20)

Yafang Zhang, Ke Fu, Cheng Wang, Cheng Ma, Lihong Gong, Honglin Zhou, Xinyan Xue, Cheng Peng & Yunxia Li. (2023) Protective effects of dietary quercetin on cerebral ischemic injury: pharmacology, pharmacokinetics and bioavailability-enhancing nanoformulations. Food & Function 14:10, pages 4470-4489.
Crossref
Marilena Bohley, Andrea E. Dillinger, Barbara M. Braunger, Ernst R. Tamm & Achim Goepferich. (2023) Intravenous injection of cyclosporin A loaded lipid nanocapsules fights inflammation and immune system activation in a mouse model of diabetic retinopathy. Drug Delivery and Translational Research.
Crossref
María Constanza Paz, Cristian Alan Rossetti, María Lina Formica & Santiago Daniel Palma. 2023. Nanotechnology in Ophthalmology. Nanotechnology in Ophthalmology 285 304 .
Sumit Mukherjee, Punyatoya Panda & Monalisa Mishra. 2023. Applications of Multifunctional Nanomaterials. Applications of Multifunctional Nanomaterials 329 364 .
Deep Shikha Sharma, Monica Gulati, Sachin Kumar Singh, Pankaj Kumar Singh & Sheetu Wadhwa. 2022. Multifunctional Nanocarriers. Multifunctional Nanocarriers 401 418 .
Ahmed Olatunde, Habibu Tijjani, Boluwatife L. Afolabi, Oluwafemi A. Ojo, Sunday A. Onikanni, Babatunji E. Oyinloye, Basiru O. Ajiboye & Abdulwahab Lasisi. 2022. Applications of Nanotechnology in Drug Discovery and Delivery. Applications of Nanotechnology in Drug Discovery and Delivery 179 203 .
Qing Xiao, Yinu Zhao, Hongjing Sun, Jia Xu, Wenjie Li & Limo Gao. (2021) MiR-423-5p activated by E2F1 promotes neovascularization in diabetic retinopathy by targeting HIPK2. Diabetology & Metabolic Syndrome 13:1.
Crossref
Rahul Tiwari, Neeraj K. Sethiya, Anamika Sahu Gulbake, Neelesh Kumar Mehra, U.S.N. Murty & Arvind Gulbake. (2021) A review on albumin as a biomaterial for ocular drug delivery. International Journal of Biological Macromolecules 191, pages 591-599.
Crossref
Anima Debbarma, Probin Kr Roy, Samia B. Barbhuiya, Jayita Das, Laldinchhana & Hauzel Lalhlenmawia. (2021) Bioactive Compound and Nanotechnology: A Novel Delivery Perspective for Diabetic Retinopathy. Current Bioactive Compounds 17:8.
Crossref
Guodong Liu, Yanliang Wang, Khusbu Keyal, Le Feng, Conghui Zhang, Hao Wang & Fang Wang. (2021) Identification of connexin43 in diabetic retinopathy and its downregulation by O-GlcNAcylation to inhibit the activation of glial cells. Biochimica et Biophysica Acta (BBA) - General Subjects 1865:10, pages 129955.
Crossref
Sureshbabu Ram Kumar Pandian, Theivendren Panneerselvam, Parasuraman Pavadai, Saravanan Govindaraj, Vigneshwaran Ravishankar, Ponnusamy Palanisamy, Muthukumar Sampath, Murugesan Sankaranarayanan & Selvaraj Kunjiappan. (2021) Nano Based Approach for the Treatment of Neglected Tropical Diseases. Frontiers in Nanotechnology 3.
Crossref
Huan-ran Zhou, Xue-fei Ma, Wen-jian Lin, Ming Hao, Xin-yang Yu, Hong-xue Li, Cheng-ye Xu & Hong-yu Kuang. (2021) Neuroprotective Role of GLP-1 Analog for Retinal Ganglion Cells via PINK1/Parkin-Mediated Mitophagy in Diabetic Retinopathy. Frontiers in Pharmacology 11.
Crossref
Işıl Kutlutürk KaragözAdil AllahverdiyevMelehat BağırovaEmrah Şefik AbamorSahar Dinparvar. (2020) Current Approaches in Treatment of Diabetic Retinopathy and Future Perspectives. Journal of Ocular Pharmacology and Therapeutics 36:7, pages 487-496.
Crossref
Ken Zhao, Jie Liu, Gang Dong, Huan Xia, Pingan Wang, Xuan Xiao & Zhen Chen. (2020) Preliminary research on the effects and mechanisms of umbilical cord‑derived mesenchymal stem cells in streptozotocin‑induced diabetic retinopathy. International Journal of Molecular Medicine 46:2, pages 849-858.
Crossref
Yi Dong, Cheng Qian, Guangming Wan, Panshi Yan, Shenzhi Liang & Jiong Wang. (2020) Schizandrin A Protects Human Retinal Pigment Epithelial Cell Line ARPE-19 against HG-Induced Cell Injury by Regulation of miR-145. Molecular Therapy - Nucleic Acids 19, pages 42-49.
Crossref
Lixia Tang, Ke Li, Yan Zhang, Huifang Li, Ankang Li, Yuancheng Xu & Bing Wei. (2020) Quercetin liposomes ameliorate streptozotocin-induced diabetic nephropathy in diabetic rats. Scientific Reports 10:1.
Crossref
Rumaisa Rashid, Amreen Naqash, Ghulam Nabi Bader & Faheem A. Sheikh. 2020. Application of Nanotechnology in Biomedical Sciences. Application of Nanotechnology in Biomedical Sciences 99 117 .
Eliana B. Souto, Selma B. Souto, Joana R. Campos, Patricia Severino, Tatiana N. Pashirova, Lucia Y. Zakharova, Amélia M. Silva, Alessandra Durazzo, Massimo Lucarini, Angelo A. Izzo & Antonello Santini. (2019) Nanoparticle Delivery Systems in the Treatment of Diabetes Complications. Molecules 24:23, pages 4209.
Crossref
Reena Siwach, Parijat Pandey, Viney Chawla & Harish Dureja. (2019) Role of Nanotechnology in Diabetic Management. Recent Patents on Nanotechnology 13:1, pages 28-37.
Crossref
Naoki Kusunose, Takahiro Akamine, Yoshiyuki Kobayashi, Shigeo Yoshida, Kenichi Kimoto, Sai Yasukochi, Naoya Matsunaga, Satoru Koyanagi, Shigehiro Ohdo & Toshiaki Kubota. (2018) Contribution of the clock gene DEC2 to VEGF mRNA upregulation by modulation of HIF1α protein levels in hypoxic MIO-M1 cells, a human cell line of retinal glial (Müller) cells. Japanese Journal of Ophthalmology 62:6, pages 677-685.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.